These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 1551539)
1. Coagulopathy during ascites reinfusion: prevention by antiplatelet therapy. Tang HH; Salem HH; Wood LJ; Dudley FJ Gastroenterology; 1992 Apr; 102(4 Pt 1):1334-9. PubMed ID: 1551539 [TBL] [Abstract][Full Text] [Related]
2. Coagulopathy of peritoneovenous shunts: studies on the pathogenic role of ascitic fluid collagen and value of antiplatelet therapy. Salem HH; Dudley FJ; Merrett A; Perkin J; Firkin BG Gut; 1983 May; 24(5):412-7. PubMed ID: 6840615 [TBL] [Abstract][Full Text] [Related]
3. The aggregation of human platelets by ascitic fluid: a possible mechanism for disseminated intravascular coagulation complicating LeVeen shunts. Salem HH; Koutts J; Handley C; van Der Weyden MB; Dudley FJ; Firkin BG Am J Hematol; 1981 Sep; 11(2):153-7. PubMed ID: 6272573 [TBL] [Abstract][Full Text] [Related]
4. Ascites-induced LeVeen shunt coagulopathy. Ragni MV; Lewis JH; Spero JA Ann Surg; 1983 Jul; 198(1):91-5. PubMed ID: 6859998 [TBL] [Abstract][Full Text] [Related]
5. [Study on the genesis of diffuse intravascular coagulation after implantation of a peritoneal-jugular le veen shunt (author's transl)]. Murr H; Grunst J; Eisenburg J; Hiller E; Zumtobel V Klin Wochenschr; 1980 Jan; 58(2):85-90. PubMed ID: 7366121 [TBL] [Abstract][Full Text] [Related]
6. A DIC-like picture on plasma and ascitic fluid of cirrhotic patients. Patrassi GM; Sartori MT; Sgarabotto D; Sturniolo G; Boeri G; Girolami A Res Exp Med (Berl); 1988; 188(5):351-6. PubMed ID: 3147501 [TBL] [Abstract][Full Text] [Related]
7. Prevention of coagulopathy after placement of peritoneovenous shunt with replacement of ascitic fluid by normal saline solution. Biagini JR; Belghiti J; Fekete F Surg Gynecol Obstet; 1986 Oct; 163(4):315-8. PubMed ID: 3764636 [TBL] [Abstract][Full Text] [Related]
8. Disseminated intravascular coagulation. Complication of LeVeen peritoneovenous shunts. Lerner RG; Nelson JC; Corines P; del Guercio LR JAMA; 1978 Nov; 240(19):2064-6. PubMed ID: 702700 [TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic study in plasma and ascitic fluid of cirrhotic patients before and after ascites concentration; reinfusion technique. Patrassi GM; Martinelli S; Sturniolo GC; Cappellato MG; Vicariotto M; Girolami A Eur J Clin Invest; 1985 Aug; 15(4):161-5. PubMed ID: 2412833 [TBL] [Abstract][Full Text] [Related]
10. Procoagulant activity of ascitic fluid in hepatic cirrhosis: in vivo and in vitro. Phillips LL; Rodgers JB Surgery; 1979 Nov; 86(5):714-21. PubMed ID: 494063 [TBL] [Abstract][Full Text] [Related]
11. Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites. Zaak D; Paquet KJ; Kuhn R Z Gastroenterol; 2001 Jan; 39(1):5-10. PubMed ID: 11215366 [TBL] [Abstract][Full Text] [Related]
12. [Coagulant and procoagulant factors in ascitic fluid--about etiology DIC induced by ascitic fluid infusion (author's transl)]. Ojiro M Igaku Kenkyu; 1981 Oct; 51(4):177-85. PubMed ID: 7331734 [No Abstract] [Full Text] [Related]
13. Coagulant, fibrinolytic, and aggregating activity in ascitic fluid. Baele G; Rasquin K; Barbier F Am J Gastroenterol; 1986 Jun; 81(6):440-3. PubMed ID: 3706262 [TBL] [Abstract][Full Text] [Related]
14. [Disseminated intravascular coagulation caused by re-infusion of ascitic fluid. Correlations between pro-aggregant and pro-coagulant factors of the ascitic fluid]. Armani U; Testa R; Piana A; Dellepiane F; Bonadonna R Arch Maragliano Patol Clin; 1979; 35():53-5. PubMed ID: 263696 [No Abstract] [Full Text] [Related]
15. Intravascular coagulation and ascitic-fluid infusion. Lee WM Ann Intern Med; 1979 Aug; 91(2):319. PubMed ID: 464483 [No Abstract] [Full Text] [Related]